Jun 20, 2017
Cure SMA, a leading national non-profit organization dedicated to the treatment and cure of spinal muscular atrophy, today announced the launch of Phase 2 of the Spinal Muscular Atrophy (SMA) Industry Collaboration.
May 12, 2017
The Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), part of the U.S.
May 09, 2017
Cure SMA has awarded a $75,000 research grant to Chris Lorson, PhD, at the University of Missouri, for his project, "Examining the role of astrocytes and the influence upon lower motor neuron susceptibility in SMA." SMA is caused by a mutation in the...
May 03, 2017
Cure SMA has awarded a $140,000 research grant to Christine DiDonato, PhD, Ann & Robert H.
Apr 07, 2017
Cure SMA has awarded a $30,000 research grant to Remy Bordonne, PhD, at CNRS-Centre National de Recherche Scientifique, for his project, "Identification of the protective mechanism of an SMN modifier gene using S. pombe as a model organism".
Mar 28, 2017
Cure SMA has awarded a $140,000 research grant to Joceyln Côté, PhD, at The University of Ottawa, for his project, "Investigating the mechanism by which SMN regulates translation: identification of novel therapeutic targets." Understanding the function...
Mar 16, 2017
Cure SMA has awarded a $140,000 research grant to Arthur Burghes, PhD, at The Ohio State University, for his project, "Identification of SMA modifiers and deletion/duplication junctions in the SMA region." All individuals with SMA lack the SMN1 gene, but.
Mar 06, 2017
Cure SMA, a national non-profit dedicated to the treatment and cure of spinal muscular atrophy, in partnership with members of the SMA Newborn Screening Coalition, have announced that spinal muscular atrophy (SMA) has been submitted to the Recommended...
Dec 27, 2016
On Friday, December 23, the FDA announced that it has approved SpinrazaTM (nusinersen) to treat spinal muscular atrophy, making it the first-ever FDA-approved therapy for SMA.
Aug 18, 2016
Join them as they surf to wipe out spinal muscular atrophy (SMA).